nagi bioscience
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
nagi bioscience has raised €1.7M across 1 funding round, most recently a Seed round in Oct 2019. Based in Lausanne, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.7M
€1,659,445
Funding rounds
1
Investors
0
distinct backers
Active since
2019-10
latest 2019-10
Funding by year
EUR raised per yearnagi bioscience — funding by year — interactive chart.
Data table
| nagi bioscience — funding by year | |
|---|---|
| 2019 | €1.7M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Seed | €1.7M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData